Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Franca, Sartor"'
Publikováno v:
Vaccines, Vol 12, Iss 1, p 26 (2023)
Cancer vaccines, a burgeoning strategy in cancer treatment, are exploring innovative administration routes to enhance patient and medical staff experiences, as well as immunological outcomes. Among these, oral administration has surfaced as a particu
Externí odkaz:
https://doaj.org/article/11c4c574582c406eb84c00ea7879a2e1
Autor:
Chiara, Zanusso, Eva, Dreussi, Roberto, Bortolus, Chiara, Romualdi, Sara, Gagno, Elena, De Mattia, Loredana, Romanato, Franca, Sartor, Luca, Quartuccio, Erika, Cecchin, Giuseppe, Toffoli
Publikováno v:
International Journal of Molecular Sciences
Up to 30–50% of patients with locally advanced prostate cancer (PCa) undergoing radiotherapy (RT) experience biochemical recurrence (BCR). The immune system affects the RT response. Immunogenetics could define new biomarkers for personalization of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f892b449066cb43aa128c9e254d01fe7
https://pubmed.ncbi.nlm.nih.gov/31035590
https://pubmed.ncbi.nlm.nih.gov/31035590
Autor:
Francesco, Comello, Lisa Dal Cin, Bignucolo, Alessia, Mezzalira, Silvia, Roncato, Rossana, Tania Di Raimo, Francesco, Angelini, Viola, Cappato, Franca, Sartor, Luisa, Foltran, Massimiliano, Berretta, Antonio Di Paoli, Michela, Guardascione, Puglisi, Fabio, Adolfo, Favaretto, Mario, D’Andrea, Erika, Cecchin, KONISHI DE TOFFOLI, Giuseppe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::8b2306f6711240a6966a31fc762d65a1
http://hdl.handle.net/11577/3321575
http://hdl.handle.net/11577/3321575
Autor:
Giorgio Giorda, Sara Gagno, Elena De Mattia, Elena Poletto, Jerry Polesel, Marica Garziera, Loredana Romanato, Simona Scalone, Roberto Sorio, Erika Cecchin, Rossana Roncato, Vincenzo Canzonieri, Franca Sartor, Giuseppe Toffoli
Publikováno v:
International Journal of Molecular Sciences
Somatic mutations in TP53 are a hallmark of high-grade serous ovarian cancer (HGSOC), although their prognostic and predictive value as markers is not well defined. Next-generation sequencing (NGS) can identify novel mutations with high sensitivity,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0afb84288044cac84edd28ee73ab8164
https://www.mdpi.com/1422-0067/19/5/1510
https://www.mdpi.com/1422-0067/19/5/1510
Autor:
Stefania Nobili, Giuseppe Toffoli, Erika Cecchin, Rossana Roncato, Angela Buonadonna, Elena De Mattia, Michela Guardascione, Antonino De Paoli, Eva Dreussi, Jerry Polesel, E. Palazzari, Alessia Bignucolo, Federico Innocenti, Mario D'Andrea, Massimiliano Berretta, Adolfo Favaretto, Enrico Mini, Luisa Foltran, Chiara Dalle Fratte, Franca Sartor, Marica Garziera, Fabrizio Ecca
Publikováno v:
Clinical Pharmacology & Therapeutics
Lack of information on the clinical utility of preemptive DPYD screening before fluoropyrimidine treatment is a major barrier preventing its use in clinical practice. This study aimed to define the association between DPYD variants and fluoropyrimidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::241461c0fa9c3ff50994266f117c9150
http://hdl.handle.net/11570/3178594
http://hdl.handle.net/11570/3178594
Autor:
Erika Cecchin, Elena De Mattia, Loredana Romanato, Franca Sartor, Chiara Zanusso, Chiara Romualdi, Sara Gagno, Eva Dreussi, Giuseppe Toffoli, Luca Quartuccio, Roberto Bortolus
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 9
International Journal of Molecular Sciences, Vol 20, Iss 9, p 2082 (2019)
Volume 20
Issue 9
International Journal of Molecular Sciences, Vol 20, Iss 9, p 2082 (2019)
Up to 30&ndash
50% of patients with locally advanced prostate cancer (PCa) undergoing radiotherapy (RT) experience biochemical recurrence (BCR). The immune system affects the RT response. Immunogenetics could define new biomarkers for personaliz
50% of patients with locally advanced prostate cancer (PCa) undergoing radiotherapy (RT) experience biochemical recurrence (BCR). The immune system affects the RT response. Immunogenetics could define new biomarkers for personaliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d8de29705f9cc7ed2f9a0a62e1c1a1
https://doi.org/10.3390/ijms20092082
https://doi.org/10.3390/ijms20092082
Autor:
Giuseppe Toffoli, Stefano Martelossi, Giuliana Decorti, Gabriele Stocco, Massimo Fontana, Tullio Giraldi, Paolo Lionetti, Fiora Bartoli, Franca Sartor, Alessandro Ventura, Arrigo Barabino
Publikováno v:
Digestive Diseases and Sciences. 51:474-479
Inflammatory bowel disease (IBD) has been related to mutations of methylenetetrahydrofolate reductase (MTHFR), a critical enzyme in the metabolism of folate and methionine, both of which are important factors in DNA methylation and synthesis. A mutat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd68cb997e9cd90a3da2c5b29a0367b
https://doi.org/10.1007/s10620-006-3158-3
https://doi.org/10.1007/s10620-006-3158-3
Autor:
Valli De Re, Maria Paola Simula, Franca Sartor, Michele Visentin, Alessandra Petrucco, Giuseppe Toffoli
Publikováno v:
International journal of oncology. 34(5)
Multi-drug resistance (MDR) limits the effectiveness of chemotherapy. P-glycoprotein encoded by the MDR1 gene, is known to be implicated in MDR phenotype, but other factors could be determinant in MDR. The aim of this study was to investigate new mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25ab3ea8b7c30e7fa80c2edf88f7a097
https://pubmed.ncbi.nlm.nih.gov/19360340
https://pubmed.ncbi.nlm.nih.gov/19360340
Autor:
Giuseppe, Toffoli, Roberta, Gafà, Antonio, Russo, Giovanni, Lanza, Riccardo, Dolcetti, Franca, Sartor, Massimo, Libra, Alessandra, Viel, Mauro, Boiocchi
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(2)
Gene silencing by hypermethylation plays an important role in proximal colon carcinogenesis. Conversely, DNA hypomethylation has been associated with distal colon cancer (CLC). Methylenetetrahydrofolate reductase (MTHFR) catalyzes the conversion of 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::723f43b7b34e5eaaae9df01219e9c0e7
https://pubmed.ncbi.nlm.nih.gov/12576444
https://pubmed.ncbi.nlm.nih.gov/12576444
Autor:
Antonio Russo, Mauro Boiocchi, Salvatore Tumolo, Federico Innocenti, Giuseppe Toffoli, Enrico Mini, Franca Sartor, Giuseppe Corona
Publikováno v:
International journal of cancer. 103(3)
MTHFR is a critical enzyme that regulates the metabolism of folate and methionine, both of which are important factors in DNA methylation and synthesis. Subjects with the 677C-->T variant have impaired remethylation of Hcy to methionine that could de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbcbab8ff88884bc82304ee59fba4356
https://pubmed.ncbi.nlm.nih.gov/12471611
https://pubmed.ncbi.nlm.nih.gov/12471611